Literature DB >> 9849933

Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models.

H Mamitsuka1.   

Abstract

The binding of a major histocompatibility complex (MHC) molecule to a peptide originating in an antigen is essential to recognizing antigens in immune systems, and it has proved to be important to use computers to predict the peptides that will bind to an MHC molecule. The purpose of this paper is twofold: First, we propose to apply supervised learning of hidden Markov models (HMMs) to this problem, which can surpass existing methods for the problem of predicting MHC-binding peptides. Second, we generate peptides that have high probabilities to bind to a certain MHC molecule, based on our proposed method using peptides binding to MHC molecules as a set of training data. From our experiments, in a type of cross-validation test, the discrimination accuracy of our supervised learning method is usually approximately 2-15% better than those of other methods, including backpropagation neural networks, which have been regarded as the most effective approach to this problem. Furthermore, using an HMM trained for HLA-A2, we present new peptide sequences that are provided with high binding probabilities by the HMM and that are thus expected to bind to HLA-A2 proteins. Peptide sequences not shown in this paper but with rather high binding probabilities can be obtained from the author.

Mesh:

Substances:

Year:  1998        PMID: 9849933     DOI: 10.1002/(sici)1097-0134(19981201)33:4<460::aid-prot2>3.0.co;2-m

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  39 in total

1.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

2.  Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.

Authors:  Morten Nielsen; Claus Lundegaard; Peder Worning; Sanne Lise Lauemøller; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

3.  Modeling the structure of bound peptide ligands to major histocompatibility complex.

Authors:  Joo Chuan Tong; Tin Wee Tan; Shoba Ranganathan
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

4.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

Authors:  Pedro A Reche; John-Paul Glutting; Hong Zhang; Ellis L Reinherz
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

5.  Predicting MHC-II binding affinity using multiple instance regression.

Authors:  Yasser EL-Manzalawy; Drena Dobbs; Vasant Honavar
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2011 Jul-Aug       Impact factor: 3.710

Review 6.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

7.  The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.

Authors:  Christina Bade-Döding; Alex Theodossis; Stephanie Gras; Lars Kjer-Nielsen; Britta Eiz-Vesper; Axel Seltsam; Trevor Huyton; Jamie Rossjohn; James McCluskey; Rainer Blasczyk
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

8.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.

Authors:  Huynh-Hoa Bui; John Sidney; Bjoern Peters; Muthuraman Sathiamurthy; Asabe Sinichi; Kelly-Anne Purton; Bianca R Mothé; Francis V Chisari; David I Watkins; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

9.  Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.

Authors:  Sergio Madurga; Ignasi Belda; Xavier Llorà; Ernest Giralt
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

Review 10.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.